n this browser, the site may not be displayed correctly. We recommend that You install a more modern browser.

Chrome Safari Firefox Opera IE  
GORODISSKY & PARTNERS
PATENT AND TRADEMARK
ATTORNEYS IP LAWYERSsince 1959
pat@gorodissky.ru Ru En Jp
+7 495 937 6116
contact us www.gorodissky.ru
����
x
 
print version

About us

Ekaterina Savateeva

Ekaterina Savateeva

Patent Engineer
Ekaterinburg
send message

Education

  • Ural State Technical University (2005-2010)
  • Ural Federal University (2010-2013)

Experience

  • Ural Federal University (2010-2014)
  • Gorodissky and Partners since 2014

Languages

  • Russian
  • English
  • Patents in the field of:
    • Manufacture of pharmaceuticals and medical materials
    • Medical products
    • Washing, cleaning and polishing agents
    • Surgical equipment
    • Orthopedic aids
    • Medical instrument
    • Diagnostic and therapeutic equipment
    • Dental equipment
  • Technical fields:
    • Pharmaceuticals
    • Medicine
    • Cosmetics
  • Objects:
    • Methods of treatment, prevention and diagnosis of human and animal diseases/li>
    • Use of drugs for treatment, prevention and diagnosis/li>
    • Pharmaceutical compositions/li>
    • Medical equipment and implants
  • “2-Morpholino-5-Phenyl-6H-1,3,4-Thiadiazine Corrects Metabolic Disorders during the Development of Alloxan Diabetes Mellitus in Rats” (Bulletin of Experimental Biology and Medicine, No. 1, November, 2016. (co-authored with V. Emelianov, L. Sidorova, T. Tseitler, I. Gette, T. Bulavintseva, S. Smirnykh, N. Maksimova, N. Mochulskaya, O. Chupakhin, V. Chereshnev)
  • “Atomic-powered microscopy of erythrocytes and metabolic disturbances in experimental diabetes mellitus and its correction by lipoic acid” (Biophysics, 2016, Issue 5 (co-authored with V. Emelyanov, D. Leontiev, A. Ishchenko, T. Bulavintseva, I. Danilova)
  • “Synthesis of new 1,3,4-thiadiazines and their ability to inhibit non-enzymatic glycosylation of proteins” (Khimiko-Farmatsevticheskii Zhurnal, 2015, No. 8. (co-authored with L. Sidorova, T. Tseitler, N. Perova, V. Emelyanov, N. Maksimova, N. Mochulskaya, V. Chereshnev, O. Chupakhin)
  • “Synthesis of new 1,3,4-thiadiazines capable of inhibiting nonenzymatic glycosylation of proteins” (Pharmaceutical Chemistry Journal, No. 8, November, 2015. (co-authored with L. Sidorova, T. Tseitler, N. Perova, V. Emel'yanov, N. Maksimova, N. Mochulskaya, V. Chereshnev, O. Chupakhin)
  • “Correction of metabolic disorders in alloxan diabetes in 1,3,4-thiadiazine derivatives” (Russian Immunological Journal - 2015. No. 2 (1) (co-authored with V. Emelianov, L. Sidorova, T. Zeitler, T. Bulavintseva, I. Gette, I. Danilova, N. Maksimova, N. Mochulskaya, O. Chupakhin, V. Chereshnev)
  • Advising Russian companies on the strategy for acquiring patent protection and the exclusive right to packaging design in Russia, United States, Canada, European Union countries, CIS countries, China, India, South Korea, Mexico, Australia, New Zealand, South Africa, Japan, Brazil.
Specialists
A B C D E F G I K L M N O P R S T V Y Z All